Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Project Oncology® - Un pódcast de ReachMD
Categorías:
Guest: Vivek Subbiah, MD This episode will recap updates from the 2023 ASCO Annual Meeting regarding the abstract on comprehensive genomic profiling for non-small cell lung cancer (NSCLC). Join Dr. Vivek Subbiah, Chief of Early Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, to learn more.
